NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Thursday that its third-quarter revenues dropped 73 percent year over year as the firm trimmed its net loss.

The Menlo Park, Calif.-based single-molecule sequencing technology firm reported total revenues of $2.8 million for the quarter ended Sept. 30, down from $10.5 million for Q3 2011. Analysts, on average, had expected revenues of $3.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.